Stewart Bates - Concepedia

Author

Stewart Bates

Also Known As

G Elliott, S Bates, S. A. BATES, S. A. Bates, S. Bates, STEWART BATES, Stewart A Bates, Stewart Bates, Stewart Bates (242426), Stewart A. Bates

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Imperial College London University of Manchester Karolinska Institutet University of Amsterdam

About

Stewart Bates is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	578
2	Allergy	4	5	280
3	Engineering	2	2	96
4	Public Health	2	2	118
5	Allergy Medicine	1	2	34

Stewart Bates

Publications

Citations

H-Index

Page 1

	Year	Citations
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function Peter R. Maycox, F. M. Kelly, Adam Taylor, Molecular Psychiatry	2009	202
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation Zala Jevnikar, Jörgen Östling, Elisabeth Ax, Journal of Allergy and Clinical Immunology	2018	187
IL-17–high asthma with features of a psoriasis immunophenotype Jörgen Östling, Marleen van Geest, James Schofield, Journal of Allergy and Clinical Immunology AsthmaAllergyImmunologyIl-17–high AsthmaMedicine	2019	134
Pathway discovery using transcriptomic profiles in adult-onset severe asthma Pieter‐Paul Hekking, Matthew J. Loza, Stelios Pavlidis, Journal of Allergy and Clinical Immunology AsthmaFunctional GenomicsTranscriptomics TechnologyPathway AnalysisTranscriptomics	2017	120
Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months Mahmoud I. Abdel‐Aziz, Paul Brinkman, Susanne J. H. Vijverberg, Journal of Allergy and Clinical Immunology	2020	104
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia Michael R. Barnes, Julie Huxley‐Jones, Peter R. Maycox, Journal of Neuroscience Research	2011	91
Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial Vincent Meininger, Pierre-François Pradat, Andrea M. Corse, PLoS ONE	2014	86
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial Vincent Meininger, Angela Genge, Leonard H van den Berg, The Lancet Neurology Amyotrophic Lateral SclerosisNeurological DisorderClinical NeurologyClinical TrialsPharmacotherapy	2017	82
Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort Dave Singh, Steven M. Fox, Ruth Tal‐Singer, PLoS ONE Acute Lung InjuryAsthmaFrequent ExacerbationsPulmonary CareInflammatory Lung Disease	2014	80
Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers Dave Singh, Steven M. Fox, Ruth Tal‐Singer, Thorax	2011	75

Page 1